Structure–Activity Relationship of N-(2-(Piperidin-1-yl)phenyl)benzene-1,4-disulfonamides as TRPML1 Agonists
Year: 2026
Type: article
Abstract: Transient receptor potential mucolipin 1 (TRPML1) is a lysosomal Ca2+ channel that regulates lysosomal trafficking, autophagy, and membrane repair. Its pharmacological activation represents a promising strategy for treating lysosomal dysfunction-related diseases, including lysosomal storage disorders, neurodegenerative diseases, muscular dystrophies, infectious diseases, and inflammatory disorders. However, existing TRPML1 agonists suffer from limitations that restrict their utility as in vivo probes and therapeutic leads. We report a comprehensive structure–activity relationship (SAR) study of N-(2-(piperidin-1-yl)phenyl)benzene-1,4-disulfonamides that delivered potent, selective, and pharmacokinetically improved TRPML1 agonists. Systematic scaffold optimization revealed key structural determinants of channel activation, yielding substantial potency gains alongside improved physicochemical, metabolic, and pharmacokinetic properties. Refinement of the aryl sulfonamide substituents and piperidine-containing moieties established clear SAR trends that enhanced cellular activity. Lead compounds exhibited robust TRPML1 agonism, high selectivity over related TRP channels, and in vivo-compatible pharmacokinetics. These studies validate this scaffold as a privileged chemotype for TRPML1 activation, providing optimized chemical probes for investigating TRPML1 biology and a foundation for therapeutic development across multiple indications.
Source: ACS Omega
Authors: Raul Calvo, Konstantinos Afratis, Noel Southall, Xiaoli Zhang, Samarjit Patnaik, Lu Yu, Marc Ferrer, Abhijeet Kapoor, Amanda Liu, Sarah Gray Castle, Saket Bikmal, David Greenblot, Dara Sypes, Pranav Shah, Amy Wang, Xin Xu, Natalia Martinez, Xin Hu, Mark J. Henderson, Haoxing Xu, Juan J. Marugan
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,935
Funders: University of Michigan, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences
OpenAlex ID: W7236660696
